Cargando…

SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patients

BACKGROUND: Optimal antibiotic dosing is key to maximising patient survival, and minimising the emergence of bacterial resistance. Evidence-based antibiotic dosing guidelines for critically ill patients receiving RRT are currently not available, as RRT techniques and settings vary greatly between IC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roberts, Jason A., Choi, Gordon Y. S., Joynt, Gavin M., Paul, Sanjoy K., Deans, Renae, Peake, Sandra, Cole, Louise, Stephens, Dianne, Bellomo, Rinaldo, Turnidge, John, Wallis, Steven C., Roberts, Michael S., Roberts, Darren M., Lassig-Smith, Melissa, Starr, Therese, Lipman, Jeffrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773999/ https://www.ncbi.nlm.nih.gov/pubmed/26932762 http://dx.doi.org/10.1186/s12879-016-1421-6

Ejemplares similares

A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics
por: Roberts, Darren M, et al.
Publicado: (2015)

Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds
por: Udy, Andrew A, et al.
Publicado: (2014)

Systematic Multi-Domain Alzheimer’s Risk Reduction Trial (SMARRT): Study Protocol
por: Yaffe, Kristine, et al.
Publicado: (2019)

A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
por: Sime, Fekade B., et al.
Publicado: (2019)

Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction
por: Sime, Fekade B., et al.
Publicado: (2019)

Cerebrospinal Fluid Penetration of Ceftolozane-Tazobactam in Critically Ill Patients with an Indwelling External Ventricular Drain
por: Sime, Fekade B., et al.
Publicado: (2020)

Measurement of tissue cortisol levels in patients with severe burns: a preliminary investigation
por: Cohen, Jeremy, et al.
Publicado: (2009)

Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients
por: Sime, Fekade B., et al.
Publicado: (2018)

Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
por: Sime, Fekade Bruck, et al.
Publicado: (2012)

Engaging Patients to Design the Systematic Multi-Domain Alzheimer’s Risk Reduction Trial (SMARRT) Intervention: Findings from a Web-Based Survey
por: Marcum, Zachary A., et al.
Publicado: (2020)

Continuous beta-lactam infusion in critically ill patients: the clinical evidence
por: Abdul-Aziz, Mohd H, et al.
Publicado: (2012)

Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patients
por: Sime, Fekade B., et al.
Publicado: (2019)

Augmented renal clearance in traumatic brain injury
por: Udy, A, et al.
Publicado: (2010)

DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic
por: Roberts, Jason A, et al.
Publicado: (2012)

Scoping review on diagnostic criteria and investigative approach in sepsis of unknown origin in critically ill patients
por: Ling, Lowell, et al.
Publicado: (2022)

A Narrative Review on the Approach to Antimicrobial Use in Ventilated Patients with Multidrug Resistant Organisms in Respiratory Samples—To Treat or Not to Treat? That Is the Question
por: Ling, Lowell, et al.
Publicado: (2022)

A comparison of CKD-EPI estimated glomerular filtration rate and measured creatinine clearance in recently admitted critically ill patients with normal plasma creatinine concentrations
por: Udy, Andrew A, et al.
Publicado: (2013)

Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study
por: Blot, Stijn, et al.
Publicado: (2014)

Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study
por: Sinnollareddy, Mahipal G, et al.
Publicado: (2015)

COVID-19: A critical care perspective informed by lessons learnt from other viral epidemics
por: Ling, Lowell, et al.
Publicado: (2020)

An Integrated Dialysis Pharmacometric (IDP) Model to Evaluate the Pharmacokinetics in Patients Undergoing Renal Replacement Therapy
por: Broeker, Astrid, et al.
Publicado: (2020)

Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?
por: Udy, Andrew A, et al.
Publicado: (2015)

We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
por: Cotta, Menino Osbert, et al.
Publicado: (2016)

Antibiotic dosing in obesity: a BIG challenge
por: Hanrahan, Timothy P., et al.
Publicado: (2016)

Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted
por: Roberts, Darren M, et al.
Publicado: (2007)

Antibiotic dosing in critically ill patients with septic shock and on continuous renal replacement therapy: can we resolve this problem with pharmacokinetic studies and dosing guidelines?
por: Roberts, Jason A, et al.
Publicado: (2014)

Complete Genome Sequence and Methylome Analysis of Micrococcus luteus SA211, a Halophilic, Lithium-Tolerant Actinobacterium from Argentina
por: Martínez, F. L., et al.
Publicado: (2019)

Aggressive malignant phyllodes tumor
por: Roberts, Nathan, et al.
Publicado: (2015)

Preliminary investigation into the response of free cortisol to the low-dose corticotrophin test in patients with septic shock
por: Cohen, J, et al.
Publicado: (2008)

The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study
por: Shekar, Kiran, et al.
Publicado: (2014)

Peri-operative pharmacokinetics of cefazolin prophylaxis during valve replacement surgery
por: Alli, Ahmad, et al.
Publicado: (2023)

Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections
por: Abdul-Aziz, Mohd H., et al.
Publicado: (2017)

Recovery rates of combination antibiotic therapy using in vitro microdialysis simulating in vivo conditions
por: Dhanani, Jayesh A., et al.
Publicado: (2018)

Conventional Pig as Animal Model for Human Renal Drug Excretion Processes: Unravelling the Porcine Renal Function by Use of a Cocktail of Exogenous Markers
por: Dhondt, Laura, et al.
Publicado: (2020)

Optimal dosing of cefotaxime and desacetylcefotaxime for critically ill paediatric patients. Can we use microsampling?
por: Guerra Valero, Yarmarly C, et al.
Publicado: (2022)

Fixational eye movements during viewing of dynamic natural scenes
por: Roberts, James A., et al.
Publicado: (2013)

Antibiotic dosing in the 'at risk' critically ill patient: Linking pathophysiology with pharmacokinetics/pharmacodynamics in sepsis and trauma patients
por: Roberts, Jason A, et al.
Publicado: (2011)

How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?
por: Wong, Gloria, et al.
Publicado: (2014)

The pharmacokinetics of cefazolin in patients undergoing elective & semi-elective abdominal aortic aneurysm open repair surgery
por: Douglas, Alexandra, et al.
Publicado: (2011)

Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis
por: Billot, Laurent, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0in47bqmfirumokohe36jub46i